Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1530012
PUBLISHER: Grand View Research | PRODUCT CODE: 1530012
Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal Type, By Drug Class, By Dosage Form, By Country, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Europe Veterinary Antibiotics Market Growth & Trends:
The Europe veterinary antibiotics market size is expected to reach USD 1.34 billion by 2030, registering a CAGR of 2.25% during the forecast period, according to a new report by Grand View Research, Inc. The rising focus on animal-only antibiotics and ionophores, the launch of new products, and the increasing use of veterinary antibiotics are some of the major factors augmenting the industry's growth. In addition, the rising prevalence and incidence of livestock diseases and concerns regarding zoonoses are further propelling the industry's growth. The COVID-19 pandemic has affected the veterinary antibiotic business operations of key players and resulted in declined financial performance during the initial time.
The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, with the easing of restrictions, manufacturers were able to supply antibiotics to meet the necessary veterinary requirements. Few major players have reported significant growth in antibiotic sales despite the pandemic. For instance, Virbac's bovine antibiotic sales grew from USD 66.98 million in 2020 to USD 79.30 million in 2021. The global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Despite the regulatory changes implemented by the European Medicines Agency (EMA) for restriction and ban on routine antibiotic use, the overall sales of veterinary antimicrobial active ingredients have observed significant growth in the past few years.
For instance, according to the EMA, overall veterinary antimicrobial active substance sales grew from 5,282 tonnes in 2019 to 5,562 tonnes in 2020. Furthermore, major players, such as Elanco, have shifted their focus to animal-only antibiotics, as a measure to address antibiotic resistance while also protecting animal health. Key players are implementing various strategic initiatives, such as mergers, partnerships, acquisitions, collaborations, and new product launches, to maintain their competitive edge. For instance, in December 2021, Virbac, in collaboration with Pharmgate, launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These activities are expected to intensify the competition between major antibiotic manufacturers in the coming years.
Europe Veterinary Antibiotics Market Report Highlights:
- The cattle animal type segment accounted for the largest revenue share in 2023 owing to the easy availability of cattle antibiotics and increased consumption of beef & dairy products
- By drug class, the penicillin segment held the largest revenue share in 2023. Penicillinis one of the most commonly sold antibiotic drug classes in Europe for veterinary application
- The oral solution segment led the market in 2023 owing to the easy & convenient usage of these dosage forms. These solutions are preferably dispensed in the drinking water
- Key factors contributing to the notable share of the U.K. include the easy availability of veterinary antibiotics and an increase in pet ownership & pet insurance rates
- The industry is fairly competitive owing to the presence of major players. Various strategic initiatives implemented by companies are greatly contributing to the growth of the industry.
Product Code: GVR-4-68039-988-4
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Europe Veterinary Antibiotics Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.2.5. Industry Analysis - Porter's Five Forces
- 3.2.5.1. Bargaining power of the suppliers
- 3.2.5.2. Bargaining power of the buyers
- 3.2.5.3. Threats of substitution
- 3.2.5.4. Threats from new entrants
- 3.2.5.5. Competitive rivalry
- 3.2.6. PESTEL Analysis
- 3.2.6.1. Political landscape
- 3.2.6.2. Economic and Social landscape
- 3.2.6.3. Technological landscape
- 3.3. Estimated Animal Population, By Key Species, Key Countries, 2023
- 3.4. Pricing Analysis
- 3.5. Technology Trend Analysis
- 3.6. Product Pipeline Analysis
- 3.7. Overall Estimated Sales Of Antimicrobial VMPs (Active Substance) In Tonnes, By European countries, 2023
- 3.8. Estimated Sales Of Antimicrobial Active Substances in Production Animals in Europe, By Antimicrobial Class, 2023
- 3.9. Regulatory framework
- 3.10. COVID-19 Impact Analysis
Chapter 4. Europe Veterinary Antibiotics Market: Animal type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Europe Veterinary Antibiotics Market: Animal type Movement Analysis, USD Billion, 2023 & 2030
- 4.2.1. Pigs
- 4.2.1.1. Pigs Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 4.2.2. Cattle
- 4.2.2.1. Cattle Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 4.2.3. Sheep & Goats
- 4.2.3.1. Sheep & Goats Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 4.2.4. Poultry
- 4.2.4.1. Poultry Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 4.2.5. Others
- 4.2.5.1. Other Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 4.2.1. Pigs
Chapter 5. Europe Veterinary Antibiotics Market: Drug Class Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Europe Veterinary Antibiotics Market: Drug class Movement Analysis, USD Billion, 2023 & 2030
- 5.2.1. Tetracyclines
- 5.2.1.1. Tetracyclines Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.2. Penicillins
- 5.2.2.1. Penicillins Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.3. Sulfonamides
- 5.2.3.1. Sulfonamides Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.4. Macrolides
- 5.2.4.1. Macrolides Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.5. Trimethoprim
- 5.2.5.1. Trimethoprim Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.6. Lincosamides
- 5.2.6.1. Lincosamides Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.7. Polymyxins
- 5.2.7.1. Polymyxins Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.8. Aminoglycosides
- 5.2.8.1. Aminoglycosides Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.9. Fluoroquinolones
- 5.2.9.1. Fluoroquinolones Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.10. Pleuromutilins
- 5.2.10.1. Pleuromutilins Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.11. Other Drug Class
- 5.2.11.1. Other Drug Class Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 5.2.1. Tetracyclines
Chapter 6. Europe Veterinary Antibiotics Market: Dosage form Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Europe Veterinary Antibiotics Market: Dosage form Movement Analysis, USD Billion, 2023 & 2030
- 6.2.1. Oral Powders
- 6.2.1.1. Oral Powders Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 6.2.2. Oral Solutions
- 6.2.2.1. Oral Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 6.2.3. Injections
- 6.2.3.1. Injections Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 6.2.4. Other Dosage Form
- 6.2.4.1. Other Dosage Form Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
- 6.2.1. Oral Powders
Chapter 7. Europe Veterinary Antibiotics Market: Country Estimates & Trend Analysis
- 7.1. Country Market Share Analysis, 2023 & 2030
- 7.2. Country Market Dashboard
- 7.3. Country Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.4.1. UK
- 7.4.1.1. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. France
- 7.4.3.1. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Italy
- 7.4.4.1. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.5. Spain
- 7.4.5.1. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.6. Denmark
- 7.4.6.1. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.8. Norway
- 7.4.8.1. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.9. Netherlands
- 7.4.9.1. Netherlands market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.10. Belgium
- 7.4.10.1. Belgium market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.11. Hungary
- 7.4.11.1. Hungary market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.12. Poland
- 7.4.12.1. Poland market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.13. Portugal
- 7.4.13.1. Portugal market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.14. Romania
- 7.4.14.1. Romania market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.1. UK
Chapter 8. Competitive Landscape
- 8.1. Company Participant Categorization
- 8.2. Company Market Position Analysis/ Heap Map Analysis
- 8.3. Company Profile
- 8.3.1. Merck & Co., Inc.
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Ceva Sante Animale
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Vetoquinol
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Zoetis Services LLC
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Boehringer Ingelheim International GmbH
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Dechra Pharmaceuticals PLC
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Elanco Animal Health Incorporated
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Virbac S.A.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Calier
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Bimeda, Inc.
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Provident Pharmaceuticals SA/NV
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Norbrook Laboratories
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.1. Merck & Co., Inc.
Product Code: GVR-4-68039-988-4
List of Tables
- Table 1. List of Secondary Sources
- Table 2. List of Abbreviations
- Table 3. Europe Veterinary Antibiotics Market, By Country, 2018 - 2030 (USD Billion)
- Table 4. Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 5. Europe Veterinary Antibiotics Market, By Drug class, 2018 - 2030 (USD Billion)
- Table 6. Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 7. Europe Veterinary Antibiotics Market, By Country, 2018 - 2030 (USD Billion)
- Table 8. Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 9. Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 10. Europe Veterinary Antibiotics Market, By Dosage Form, 2018 - 2030 (USD Billion)
- Table 11. UK Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 12. UK Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 13. UK Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 14. Germany Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 15. Germany Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 16. Germany Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 17. France Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 18. France Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 19. France Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 20. Italy Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 21. Italy Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 22. Italy Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 23. Spain Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 24. Spain Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 25. Spain Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 26. Denmark Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 27. Denmark Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 28. Denmark Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 29. Sweden Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 30. Sweden Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 31. Sweden Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 32. Norway Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 33. Norway Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 34. Norway Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 35. Netherlands Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 36. Netherlands Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 37. Netherlands Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 38. Belgium Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 39. Belgium Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 40. Belgium Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 41. Hungary Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 42. Hungary Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 43. Hungary Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 44. Poland Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 45. Poland Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 46. Poland Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 47. Portugal Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 48. Portugal Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 49. Portugal Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
- Table 50. Romania Europe Veterinary Antibiotics Market, By Animal type, 2018 - 2030 (USD Billion)
- Table 51. Romania Europe Veterinary Antibiotics Market, By Drug Class, 2018 - 2030 (USD Billion)
- Table 52. Romania Europe Veterinary Antibiotics Market, By Dosage form, 2018 - 2030 (USD Billion)
List of Figures
- Fig. 1 Europe Veterinary Antibiotics market segment scope and defination
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 QFD modeling for market share assessment
- Fig. 8 Market formulation & validation
- Fig. 9 Market outlook (2023)
- Fig. 10 Strategy framework
- Fig. 11 Market driver relevance analysis (Current & future impact)
- Fig. 12 Market restraint relevance analysis (Current & future impact)
- Fig. 13 Porter's five forces analysis
- Fig. 14 PESTLE analysis
- Fig. 15 Europe Veterinary Antibiotics market: Animal type movement analysis
- Fig. 16 Europe Veterinary Antibiotics market: Animal type segment dashboard
- Fig. 17 Europe Veterinary Antibiotics market Animal type outlook: Key takeaways
- Fig. 18 Pigs Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 19 Cattle Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 20 Sheep & Goats Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 21 Poultry Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 22 Other Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 23 Europe Veterinary Antibiotics market: Drug Class movement analysis
- Fig. 24 Europe Veterinary Antibiotics market Drug Class outlook: Key takeaways
- Fig. 25 Tetracyclines Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 26 Penicillins Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 27 Sulfonamides Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 28 Macrolides Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 29 Trimethoprim Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 30 Lincosamides Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 31 Polymyxins Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 32 Aminoglycosides Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 33 Fluoroquinolones Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 34 Pleuromutilins Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 35 Other Drug Class Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 36 Europe Veterinary Antibiotics market: Dosage Form movement analysis
- Fig. 37 Europe Veterinary Antibiotics market Dosage Form outlook: Key takeaways
- Fig. 38 Oral Powders Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 39 Oral Solutions Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 40 Injections Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 41 Other Dosage Form Europe Veterinary Antibiotics market estimates and forecast, 2018 - 2030 (USD Billion)
- Fig. 42 Country outlook, 2023 & 2030
- Fig. 43 Country market dashboard
- Fig. 44 Country market place: Key takeaways
- Fig. 45 Europe Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 46 UK Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 47 Germany Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 48 Spain Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 49 France Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 50 Italy implantable Market, 2018 - 2030 (USD Billion)
- Fig. 51 Denmark Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 52 Sweden Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 53 Norway Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 54 Netherlands Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 55 Belgium Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 56 Poland Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 57 Portugal Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 58 Hungary implantable Market, 2018 - 2030 (USD Billion)
- Fig. 59 Romania Europe Veterinary Antibiotics Market, 2018 - 2030 (USD Billion)
- Fig. 60 Heat map analysis
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.